Novartis’ multibillion transformation

Novartis launched a major overhaul of its business, unveiling a series of multibillion-dollar deals with GSK and Eli Lilly & Co. The beginning or end of another wave of M&A activity?

Read the source article at The Boston Globe

About the Author

Leave a Reply